Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Medical Malpractice Law & StrategyKickerColumns & DepartmentsSectionsLJN Newsletters

Drug & Device News

Congress Moves to Control Opioid Abuse Epidemic

In May, Congress passed a slate of bills aimed at combating the growing opioid abuse problem in the United States. Unfortunately, no monies were allocated to implementing them. One of the measures is H.R. 4641, a proposed law whose fairly self-descriptive title is: “To provide for the establishment of an inter-agency task force to review, modify, and update best practices for pain management and prescribing pain medication, and for other purposes.” It calls for the formation of a task force ' made up of patients, medical professionals, hospitals, pain advocacy groups, state medical boards and federal agencies ' which will be asked to consider current best practices in prescribing opioids and formulating improvements that will result in fewer overdoses and fewer people becoming addicted. According to a release issued by one of the sponsors of H.R. 4641, Rep. Susan Brooks (R-IN), the United States loses 78 Americans each day to opioid overdose. “We have to act now to stem the tide of opioid abuse in this country, and it starts with giving prescribers, law enforcement, treatment professionals and communities the tools they need to prevent opioid abuse, treat substance abuse and addiction, and prevent illegal drugs from being bought and sold,” said Brooks.

This premium content is locked for LJN Newsletters subscribers only

  • Stay current on the latest information, rulings, regulations, and trends
  • Includes practical, must-have information on copyrights, royalties, AI, and more
  • Tap into expert guidance from top entertainment lawyers and experts

For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473

Read These Next
The DOJ's Corporate Enforcement Policy: One Year Later Image

The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.

Use of Deferred Prosecution Agreements In White Collar Investigations Image

This article discusses the practical and policy reasons for the use of DPAs and NPAs in white-collar criminal investigations, and considers the NDAA's new reporting provision and its relationship with other efforts to enhance transparency in DOJ decision-making.

The DOJ's New Parameters for Evaluating Corporate Compliance Programs Image

The parameters set forth in the DOJ's memorandum have implications not only for the government's evaluation of compliance programs in the context of criminal charging decisions, but also for how defense counsel structure their conference-room advocacy seeking declinations or lesser sanctions in both criminal and civil investigations.

CLE Shouldn't Be the Only Mandatory Training for Attorneys Image

Each stage of an attorney's career offers opportunities for a curriculum that addresses both the individual's and the firm's need to drive success.

A defendant in a patent infringement suit may, during discovery and prior to a <i>Markman</i> hearing, compel the plaintiff to produce claim charts, claim constructions, and element-by-element infringement analyses.